Plum (Pureplay Skin Sciences)/D2C / BEAUTY & PERSONAL CAREUpdated: 07 May 2026

Plum Became Profitable Without Raising Capital.

Plum (Pureplay Skin Sciences) revenue, PAT, debt and cash flow — from the AOC-4 XBRL Standalone Financial Statements FY2025, Pureplay Skin Sciences (India) Private Limited (Plum).

₹402 Cr
FY2025 Revenue (+23%)
+₹25 Cr
FY2025 Net Profit
₹109 Cr
Bottom-Line Swing
₹0
Fresh Capital Raised
UnpopularVoice Editorial7 min read  ·  Financial deep dive
What the numbers actually say13 metrics
MetricReported(Narrative)Economic Reality
FY2025 Revenue₹401.85 Crup from ₹326.76 Cr (+23.0%)
FY2025 Net Profit+₹24.72 Crvs -₹84.10 Cr in FY24 (+₹108.82 Cr swing)
Profit Before Tax+₹18.88 Crvs -₹85.02 Cr in FY24
Advertising & Promotion₹139.24 Crdown 6.6% from ₹149.04 Cr
Ad / Revenue Ratio34.6%down from 45.6% in FY2024
Employee Benefits Expense₹42.61 Crup 12.5% from ₹37.87 Cr
Other Expenses₹212.71 Crdown 3.0% from ₹219.28 Cr
Operating Cash Flow+₹3.83 Crvs -₹16.64 Cr in FY24
Cash + Bank Balances₹92.42 Crdown from ₹107.53 Cr (FD reallocated)
Current Investments₹63.54 Crdown from ₹74.01 Cr
Net Worth₹197.43 Crup from ₹171.42 Cr (+₹26 Cr from earnings)
Long-Term BorrowingsZero₹3.60 Cr short-term borrowings only
Inventory₹33.61 Crrebuilt from ₹21.89 Cr

The 30-Second Summary

Plum lost ₹84 Cr last year.

This year, it made ₹25 Cr.

No new capital was raised.

Revenue grew 23% to ₹402 Cr. Advertising fell 7%. Ad-to-revenue compressed from 46% to 35%. Net worth rose ₹26 Cr from operations alone.

Plum didn't scale spend. It scaled efficiency.

What changed in FY2025?

  • Revenue grew 23%: ₹327 Cr to ₹402 Cr.
  • Advertising fell 7%: ₹149 Cr to ₹139 Cr.
  • Ad/revenue ratio compressed 11pp: 46% to 35%.
  • Other expenses fell 3%: ₹219 Cr to ₹213 Cr.
  • Bottom line swung ₹109 Cr: -₹84 Cr to +₹25 Cr.
  • OCF turned positive: +₹4 Cr (vs -₹17 Cr in FY24).
  • Net worth rose ₹26 Cr from earnings: no fresh equity raised.
  • Liquidity ₹156 Cr: cash + treasury, vs zero long-term debt.

The Turnaround, Decomposed

The bottom line moved ₹109 Cr in one year. Three lines explain it:

  • Revenue: +₹75 Cr at ~60% gross margin = ~₹47 Cr of incremental gross profit.
  • Advertising: -₹10 Cr while revenue grew 23%. Ratio compressed 11pp.
  • Inventory cycle: FY24 destocking, FY25 rebuild — ₹31 Cr P&L timing swing between periods.

The first two are durable. The third is timing. Adjusting for inventory, underlying PBT improvement is ~₹73 Cr on revenue growth of ₹75 Cr. Extreme operating leverage.

This is what scale plus marketing discipline looks like when both arrive in the same year.

The core insight

Profitability came not from cutting growth, but from paying less for it.

Where Plum Sits in the Cohort

Three D2C beauty audits in this filing cycle, all roughly the same revenue base, all with starkly different outcomes:

  • Plum: Revenue ₹402 Cr (+23%). Advertising 35% of revenue. Net profit +₹25 Cr.
  • Renee: Revenue ₹312 Cr (+63%). Advertising 49% of revenue. Net loss -₹56 Cr.
  • Pilgrim: Revenue ₹408 Cr (+105%). Advertising 57% of revenue. Net loss -₹69 Cr.
  • mCaffeine: Revenue ₹237 Cr (+23%). Advertising 40% of revenue. Net loss -₹18 Cr (consol).

Plum is the only one below 40%. It is the only one making money.

The cohort tells a clean story: D2C beauty in India is profitable when ad-to-revenue gets below 40%. Above that, the gross margin doesn't have enough headroom to absorb the operating cost stack.

The Cash and Capital Picture

The balance sheet tells the same story as the P&L: self-sufficient.

Cash and bank balances ended FY25 at ₹92.42 Cr (versus ₹107.53 Cr at March 2024). The drop is FD reallocation, not cash burn — operating cash flow was positive at +₹3.83 Cr. Current investments of ₹63.54 Cr (down from ₹74.01 Cr) reflect treasury rebalancing. Total liquidity ₹156 Cr.

Net worth rose from ₹171.42 Cr to ₹197.43 Cr — an increase of ₹26.01 Cr, almost exactly equal to the FY25 net profit (₹24.72 Cr). No fresh equity was issued; reserves grew because operations contributed.

Long-term debt is zero. Short-term borrowings of ₹3.60 Cr are negligible against the ₹156 Cr liquidity buffer.

For the first time, Plum's audit shows a company that funds its own growth.

The business now funds itself.

What FY2026 Has to Show

The FY2025 audit makes the FY2026 question precise.

Will the inventory swing reverse? ₹31 Cr of FY25 P&L improvement was timing — inventory rebuilt in FY25 will become cost recognised in FY26 unless revenue absorbs it. If FY26 revenue grows another 20%+, the larger sell-through absorbs the inventory cleanly and operating profit holds.

Will marketing stay below 40% of revenue? 35% is the new floor. Re-inflation back to 45-50% would compress operating profit toward zero. The audit shows discipline; the question is whether it holds when scale plateaus.

Will the cash position grow? With ₹156 Cr of liquidity, no debt, and ₹19 Cr of underlying PBT generation, Plum is positioned to compound from operations. If FY26 revenue and margin both hold, the cash pile expands meaningfully and optionality (acquisitions, new categories, dividend) emerges.

The risk is not the trajectory. It is staying disciplined.

Employer Health Signal

Plum (Pureplay Skin Sciences (India) Private Limited)

Filing: FY2025 standaloneMCA audited data
Solid financial footing

Growth Momentum

YoY revenue growth rate, whether growth is from continuing operations, cost trajectory

Steady

Stability

Cash + liquid assets vs burn, debt structure, operating cash flow

Strong

Profitability

PAT direction, cost-to-income ratio trend, operating leverage signals

Achieved

Funding Dependence

How much of operations is funded by equity raises vs revenue

Low

Career Upside

Revenue growth + payroll signals + ESOP structure + company stage

High

Notes

Plum (Pureplay Skin Sciences) reported the cleanest D2C beauty turnaround in this filing cycle. FY2025 net profit was ₹25 Cr versus a ₹84 Cr loss in FY2024 — a ₹109 Cr swing on revenue growth of ₹75 Cr. Advertising fell ₹10 Cr (-7%) while revenue grew 23%, dropping the ad-to-revenue ratio from 46% to 35%. Operating cash flow turned positive. Net worth rose ₹26 Cr entirely from retained earnings — no fresh capital was raised. Long-term debt is zero; total liquidity sits at ₹156 Cr against zero meaningful obligations.

What the filing confirms

  • Net profit ₹25 Cr against prior-year loss of ₹84 Cr — ₹109 Cr swing.
  • Ad-to-revenue ratio compressed 11 percentage points (46% to 35%) — only D2C beauty audit in this cycle below 40%.
  • Operating cash flow turned positive (+₹4 Cr) for the first time.
  • Net worth grew ₹26 Cr entirely from retained earnings — no external capital required.
  • Liquidity ₹156 Cr (cash + treasury) against zero long-term debt.
  • Revenue growth of 23% paired with profitability — sustainable operating model.

Risk flags from filing

  • FY25 P&L includes ~₹31 Cr inventory swing benefit; some FY26 cost recognition is timing-deferred.
  • Tax-credit-driven boost: ₹6 Cr deferred tax credit lifted reported PAT above PBT-derived figure.
  • Employee costs grew 13% on revenue growth of 23%; modest operating leverage in this line.
  • Cohort exposure: D2C beauty category is competitive; if scale plateaus, marketing discipline is the load-bearing variable.

Disclaimer: This signal is derived from audited financial filings only. It does not assess culture, management quality, career growth environment, team dynamics, or working conditions. A strong signal means the financial floor is solid. A weak signal means financial risk is present. Neither replaces your own due diligence. Scoring methodology →

Key Takeaways5 points
1PUREPLAY SKIN SCIENCES (INDIA) PRIVATE LIMITED (CIN U74120MH2013PTC248969), the parent entity behind the Plum brand, reported FY2025 standalone revenue of ₹401.85 Cr (+23.0%) on a base of ₹326.76 Cr in FY2024.
2Net profit of ₹24.72 Cr in FY2025 versus net loss of ₹84.10 Cr in FY2024 — a ₹108.82 Cr improvement at the bottom line. Profit before tax was ₹18.88 Cr (versus PBT of -₹85.02 Cr in FY24); a ₹5.84 Cr deferred tax credit added to the headline net profit.
3Advertising and promotional expense was ₹139.24 Cr, down 6.6% from ₹149.04 Cr. As a percentage of revenue: 34.6% in FY25 vs 45.6% in FY24 — an 11-point compression.
4Operating cash flow turned positive at +₹3.83 Cr (vs -₹16.64 Cr in FY24). Net worth rose from ₹171.42 Cr to ₹197.43 Cr, entirely from retained earnings — no fresh capital infusion. Financing CF was -₹5.93 Cr, a small net outflow.
5Cash and bank balances ₹92.42 Cr + current investments ₹63.54 Cr = total liquidity ₹155.96 Cr at March 2025. Long-term borrowings: zero. Short-term borrowings: ₹3.60 Cr (immaterial). Inventory rebuilt from ₹21.89 Cr to ₹33.61 Cr.